14 research outputs found

    Membrane-associated CADM1 mediates vFLIP and NEMO interactions and IKK complex activation in lipid rafts.

    No full text
    <p>(A) BC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. (B) Lipid raft fractionations from BC-3 cells stably expressing control scrambled shRNA or CADM1 shRNA were subjected to immunoprecipitation with anti-vFLIP. Samples immunoprecipitated with anti-vFLIP were immunoblotted with anti-vFLIP, anti-NEMO, and anti-CADM1. Lysates from lipid rafts fractions were examined for vFLIP, phospho-IKKα/β, total IKKα, IKKβ, NEMO, CADM1, ERK1 (marker for soluble fractions), and Lyn (lipid raft protein marker).</p

    CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation

    No full text
    <div><p>Approximately 12% of all human cancers worldwide are caused by infections with oncogenic viruses. Kaposi's sarcoma herpesvirus/human herpesvirus 8 (KSHV/HHV8) is one of the oncogenic viruses responsible for human cancers, including Kaposi’s sarcoma (KS), Primary Effusion Lymphoma (PEL), and the lymphoproliferative disorder multicentric Castleman’s disease (MCD). Chronic inflammation mediated by KSHV infection plays a decisive role in the development and survival of these cancers. NF-κB, a family of transcription factors regulating inflammation, cell survival, and proliferation, is persistently activated in KSHV-infected cells. The KSHV latent and lytic expressing oncogenes involved in NF-κB activation are vFLIP/K13 and vGPCR, respectively. However, the mechanisms by which NF-κB is activated by vFLIP and vGPCR are poorly understood. In this study, we have found that a host molecule, Cell Adhesion Molecule 1 (CADM1), is robustly upregulated in KSHV-infected PBMCs and KSHV-associated PEL cells. Further investigation determined that both vFLIP and vGPCR interacted with CADM1. The PDZ binding motif localized at the carboxyl terminus of CADM1 is essential for both vGPCR and vFLIP to maintain chronic NF-κB activation. Membrane lipid raft associated CADM1 interaction with vFLIP is critical for the initiation of IKK kinase complex and NF-κB activation in the PEL cells. In addition, CADM1 played essential roles in the survival of KSHV-associated PEL cells. These data indicate that CADM1 plays key roles in the activation of NF-κB pathways during latent and lytic phases of the KSHV life cycle and the survival of KSHV-infected cells.</p></div

    Model of the role of CADM1 in Tax-mediated NF-κB activation.

    No full text
    <p>Membrane associated CADM1 recruits Ubc13 on Tax, which causes K63-linked polyubiquitination of Tax, and association of TAX<sub>1</sub>BP<sub>1,</sub> NRP, and the NEMO/IKK complex with Tax. CADM1 also inhibits IKKα-mediated phosphorylation of TAX<sub>1</sub>BP<sub>1</sub> and disrupts the NF-κB negative regulator ubiquitin-editing enzyme A20 complex assembly that allows chronic NF-κB activation in HTLV-1 transformed cells.</p

    Tax requires CADM1 for NF-κB activation.

    No full text
    <p>(A) Lentiviral Tax was transduced in Jurkat T-cells stably expressing control scrambled shRNA or CADM1 shRNA. After 48 h, lysates were subjected to immunoblotting with anti-IκBα, anti-phospho-IκBα, anti-CADM1, anti-Tax, and anti-β-actin antibodies. (B) Primary <i>Cadm1</i><sup><i>+/+</i></sup> and <i>Cadm1</i><sup><i>−/−</i></sup> MEFs were transduced with Tax-expressing lentiviruses. After 48 h, lysates were subjected to immunoblotting with anti-IκBα, anti-phospho-IκBα, anti-CADM1, anti-Tax, and anti-β-actin antibodies. (C) Nuclear extracts from lentiviral expressing Tax in primary <i>Cadm1</i><sup><i>+/+</i></sup> and <i>Cadm1</i><sup><i>−/−</i></sup> MEFs were used for NF-κB and Oct-1 EMSA, and cytoplasmic extract were subjected to immunoblotting with anti-Tax, anti-CADM1, and anti-β-actin antibodies. (D) Lysates from HTLV-1 transformed C8166, MT-2, and MT-4 cells stably expressing control scrambled shRNA or CADM1 shRNA were subjected to immunoblotting with anti-IκBα, anti-phospho-IκBα, anti-CADM1, anti-Tax, and anti-β-actin antibodies. (E) Nuclear extracts from HTLV-1 transformed C8166, MT-2, and MT-4 cells stably expressing control scrambled shRNA or CADM1 shRNA were used for NF-κB and Oct-1 EMSA, and cytoplasmic extracts were subjected to immunoblotting with anti-CADM1 and anti-β-actin antibodies. (F) Primary <i>Cadm1</i><sup><i>+/+</i></sup> and <i>Cadm1</i><sup><i>−/−</i></sup> MEFs were transduced with Tax-expressing lentiviruses as described for panel B. After 48 hours, RNA was prepared and subjected to RT-PCR for A20, IL-6, Bfl-1, Tax, and GAPDH expression.</p

    CADM1 is required for KSHV vFLIP to activate NF-κB.

    No full text
    <p>(A) NF-κB luciferase assay using lysates of HeLa cells expressing increasing amounts of CADM1 or vFLIP. HeLa cells were transfected with increasing amounts of either CADM1 or vFLIP with κB‐TATA Luc and pRL‐tk plasmids. After 36 hours, lysates were subjected to dual luciferase assays. The lysates were also subjected to immunoblotting to examine CADM1 and vFLIP expression using anti-Flag antibody. (B) NF-κB luciferase assay using lysates of HeLa cells stably expressing control scrambled shRNA or three different CADM1 shRNAs and transfected with pRL-tk, κB-TATA Luc and vFLIP as indicated. Immunoblot analyses of CADM1 protein expression in HeLa cells after transduction with lentiviruses expressing different shRNAs targeting distinct sequences of the CADM1 transcript. (C) NF-κB luciferase assay using lysates of <i>Cadm1</i><sup><i>+/+</i></sup> and <i>Cadm1</i><sup><i>−/−</i></sup> MEFs transfected with pRL-tk internal control Renilla luciferase plasmid, κB-TATA Luc and vFLIP as indicated. The lysates were also subjected to immunoblotting to examine vFLIP expression. (D) A schematic overview of the FLAG-CADM1 deletion mutants ΔSP, ΔCP, ΔEC, ΔPDZ-BM and ΔFERM. (E) NF-κB luciferase assay of lysates of <i>Cadm1</i><sup><i>−/−</i></sup> MEFs transfected with an NF-κB firefly luciferase reporter and a renilla luciferase vector reporter together with empty vector or an expression vector for Flag-tagged wild-type CADM1, CADM1 ΔSP, CADM1 ΔCP, CADM1 ΔEC, CADM1 ΔPDZ-BM and CADM1 ΔFERM-BM with vFLIP. The lysates were also subjected to immunoblotting to examine expression of vFLIP and Flag for wild-type and deletion mutants of CADM1. Error bars represent s.e.m. of triplicates.</p

    CADM1 expression is upregulated in KSHV-infected cells.

    No full text
    <p>(A-B) Quantitative real-time PCR (qRT-PCR) analysis of CADM1 from HeLa and primary human B cells with and without KSHV infection. (C-D) qRT-PCR analysis of CADM1 from KSHV-associated PEL cell lines (BC-1, BC-3, BCBL-1, and UM-PEL-3) (error bars, s.e.m. of triplicate samples). (E-G) Western blot analysis of CADM1 and LANA in KSHV-infected HeLa, human primary B cells, and PEL cell lines (BC-1, BC-3, BCBL-1, and UM-PEL-3).</p

    CADM1 is required for PEL cell survival.

    No full text
    <p>(A) Requirement of CADM1 for the viability of PEL cell lines. Cell viability assay was performed 96 hours after BC-1, BC-3, and BCBL-1 cells were transduced with lentiviruses expressing the indicated shRNAs. Relative cell viability (%) was expressed as a percentage relative to the control cells. (B) CADM1 protein was knocked down in BC-1, BC-3, and BCBL-1 cells after lentiviral transduction expressing the indicated shRNAs. Immunoblotting was performed with whole cell lysates. (C) Flow cytometric analysis of PEL cell lines transduced with shRNAs as described in (A). Cells were stained with both annexin-V-Alexa Fluor 488 and propidium iodide (PI). The distribution of cells is indicated as a percentage in each quadrant.</p

    CADM1 is required for Tax K63-linked polyubiquitination.

    No full text
    <p>(A) Lentiviral Tax was transduced in Jurkat T-cells stably expressing control scrambled shRNA or CADM1 shRNA. After 48 hours, cells were lysed and immunoprecipitated with anti-Tax, followed by immunoblotting with anti-Ubi-K63 and anti-Tax antibodies. Lysates were examined for Tax, CADM1 and β-actin expression. (B) Lentiviral Tax was transduced in <i>Cadm1</i><sup><i>+/+</i></sup> and <i>Cadm1</i><sup><i>−/−</i></sup> MEFs. After 48 hours cells were lysed and immunoprecipitated with anti-Tax followed by immunoblotting with anti-K63-ubi and anti-Tax antibodies. Lysates were examined for Tax, CADM1, and β-actin expression. (C) Lysates from HTLV-1 transformed (C8166, MT-2, and MT-4) cells stably expressing CADM1 shRNA were immunoprecipitated with anti-Tax followed by immunoblotting with anti-K63-ubi and anti-Tax antibodies. Lysates were examined for Tax, CADM1, and β-actin expression.</p

    Tax induces CADM1 expression.

    No full text
    <p>(A) CADM1 expression in foot, tail, spleen and bone marrow (BM) tissues derived from spontaneous tumors of 14 month old control Tax-negative and Tax-positive transgenic mice. Immunoblotting was performed with anti-CADM1, Tax, and β-actin antibodies. CADM1 expression in lentiviral-transduced empty vector wildtype Tax or Tax mutants (M22 or M47) in primary MEFs (B) and Jurkat T-cells (C) was analyzed with anti-CADM1, SOCS1, Tax, and β-actin antibodies.</p

    Membrane associated CADM1 mediates K63-linked polyubiquitination of Tax and links Tax adaptor proteins in the lipid rafts.

    No full text
    <p>(A) MT-2 cells were stained with DAPI, anti-Tax, anti-CADM1, and anti-GM-130, and subjected to confocal microscopy. (B) MT-2 cells were stained with DAPI, anti-Tax, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1, and subjected to confocal microscopy. (C) Lipid raft fractionations from MT-2 cells stably expressing control scrambled shRNA or CADM1 shRNA were split into half and subjected to immunoprecipitation with either anti-Tax or anti-CADM1. Samples immunoprecipitated with anti-Tax were immunoblotted with anti-K63-ubi and anti-Tax. Samples immunoprecipitated with anti-CADM1 were immunoblotted with anti-CADM1, anti-TAX<sub>1</sub>BP<sub>1</sub>, anti-Tax, anti-NEMO, anti-Ubc13, and anti-NRP antibodies. Lysates from lipid rafts fractions were examined for Tax, phospho-IKKα/β, total IKKα, IKKβ, NEMO, CADM1, Ubc13, TAX<sub>1</sub>BP<sub>1</sub>, NRP, ERK1 (marker for soluble fractions), LAT (lipid raft protein marker) and GM1 (lipid raft marker).</p
    corecore